 |
(ethane-1,2-diylbis(oxy)bis(ethane-2,1-diyl)bis(bis(thiophene-2-ylmethyl)carbamate) |
|---|---|
| Trade Name | |
| Orphan Indication | Malignant melanoma stages IIB to IV |
| USA Market Approval | USA |
| USA Designation Date | 2017-11-08 00:00:00 |
| Sponsor | 7 Hills Pharma, LLC;8285 El Rio Street, Suite 130;Houston, Texas, 77054 |
